Stack Lab

Research a compound stack end to end — a structured protocol scaffold, how VialTalk researchers actually combine these compounds, receptor conflicts, and live COA-verified prices. Add 1–5 compounds.

5-Amino-1MQDual Incretin AgonistGHK-CuKLOWTesamorelin

5 of 5 compounds

Research signals

5-Amino-1MQRich researchRising
Dual Incretin AgonistRich researchRising
GHK-CuRich researchBreakout
KLOWRich researchRising
TesamorelinRich researchBreakout

Receptor Compatibility

Redundancy, true conflicts, and dangerous additive effects

Step 1

Receptor conflicts not yet analyzed for this stack

Analyze now →

Protocol scaffold

A structured, research-grounded protocol for this stack

Step 2

Sign in to build a structured research protocol scaffold for 5-Amino-1MQ + Dual Incretin Agonist + GHK-Cu + KLOW + Tesamorelin — phases, per-compound parameters, endpoints and washout, grounded in documented research.

Create a free account Sign in

Community data

What VialTalk researchers actually run

Step 3

No researchers have logged this exact combination yet — yours could be the first.

Log this in your journal →

Researchers are also adding

+ MOTS-c + Triple Agonist + NAD++ KPV + Glutathione + SS-31

Pricing snapshot

Best price for each compound today

Step 4

5-Amino-1MQ
from NorthStar Compounds · 18 vendors
Compare all vendors →
3 panels
$22.49 · 10mg
$2.25/mg
Dual Incretin Agonist
from Lost Coast Aminos · 21 vendors
Compare all vendors →
8 panels
$19.44 · 10mg
$1.94/mg
GHK-Cu
from Peptinexia · 18 vendors
Compare all vendors →
5 panels
$21.75 · 50mg
KLOW
from Double R Labs · 17 vendors
Compare all vendors →
6 panels
$45.49 · 80mg
$0.57/mg
Tesamorelin
from S1Research · 19 vendors
Compare all vendors →
8 panels
$30.15 · 10mg
$3.02/mg

Same “From” price shown on each compound's page (after discounts). Panels = COA assays tested. Tap “Compare all vendors” for the full breakdown.

For research and informational use only. VialTalk does not provide medical advice or dosing guidance. Community data reflects self-reported public research journals.